These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12124166)

  • 41. The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule.
    Dear AE; Medcalf RL
    Eur J Biochem; 1998 Mar; 252(2):185-93. PubMed ID: 9523687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro receptor imaging for characterization of human solid tumors.
    Del Vecchio S; Stoppelli MP; Carriero MV; Fonti R; Massa O; Li PY; Botti G; Cerra M; D'Aiuto G; Esposito G
    Nucl Med Biol; 1994 Jul; 21(5):771-4. PubMed ID: 9241653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermal growth factor-regulated signal transduction in hormone dependent and independent breast cancer.
    Akhtar N; Linstead D; Wakelam MJ
    Biochem Soc Trans; 1996 Aug; 24(3):373S. PubMed ID: 8878917
    [No Abstract]   [Full Text] [Related]  

  • 44. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of heterotrimeric G-proteins in epidermal growth factor signalling.
    Ramírez I; Tebar F; Grau M; Soley M
    Cell Signal; 1995 May; 7(4):303-11. PubMed ID: 8527298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
    Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
    Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
    Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
    Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
    Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
    Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor-binding protein activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB; Brown MD
    FEBS Lett; 1995 Dec; 376(3):177-80. PubMed ID: 7498536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease.
    Meijer-van Gelder ME; Look MP; Peters HA; Schmitt M; Brünner N; Harbeck N; Klijn JG; Foekens JA
    Cancer Res; 2004 Jul; 64(13):4563-8. PubMed ID: 15231667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RANKL Signaling and ErbB Receptors in Breast Carcinogenesis.
    Zoi I; Karamouzis MV; Adamopoulos C; Papavassiliou AG
    Trends Mol Med; 2016 Oct; 22(10):839-850. PubMed ID: 27567286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-time kinetics of ligand/cell surface receptor interactions in living cells: binding of epidermal growth factor to the epidermal growth factor receptor.
    Wilkinson JC; Stein RA; Guyer CA; Beechem JM; Staros JV
    Biochemistry; 2001 Aug; 40(34):10230-42. PubMed ID: 11513601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.
    Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ
    Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
    Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
    Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors.
    Game SM; Stone A; Scully C; Prime SS
    Carcinogenesis; 1990 Jun; 11(6):965-73. PubMed ID: 2161297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue urokinase-type plasminogen activator receptor levels in breast cancer.
    Gong SJ; Rha SY; Chung HC; Yoo NC; Roh JK; Yang WI; Lee KS; Min JS; Kim BS; Chung HC
    Int J Mol Med; 2000 Sep; 6(3):301-5. PubMed ID: 10934293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urokinase-type plasminogen activator system and breast cancer (Review).
    Han B; Nakamura M; Mori I; Nakamura Y; Kakudo K
    Oncol Rep; 2005 Jul; 14(1):105-12. PubMed ID: 15944776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urokinase and its receptor: marker of malignancy?
    Gaffney PJ; Cooke DA; Burnand KG
    Adv Exp Med Biol; 1994; 360():187-91. PubMed ID: 7872083
    [No Abstract]   [Full Text] [Related]  

  • 59. Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.
    Nicholson RI; McClelland RA; Finlay P; Eaton CL; Gullick WJ; Dixon AR; Robertson JF; Ellis IO; Blamey RW
    Eur J Cancer; 1993; 29A(7):1018-23. PubMed ID: 8098946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.